Literature DB >> 17080186

Response to Windahl et al.

Stavros C Manolagas, Robert L Jilka, Stavroula Kousteni, Teresita Bellido, Robert S Weinstein, Charles A O'Brien, Lilian Plotkin, Li Han.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 17080186      PMCID： PMC1626133          DOI： 10.1172/JCI30535

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  8 in total

1.  Estren is a selective estrogen receptor modulator with transcriptional activity.

Authors:  Sofia Movérare; Johanna Dahllund; Niklas Andersson; Ulrika Islander; Hans Carlsten; Jan-Ake Gustafsson; Stefan Nilsson; Claes Ohlsson
Journal:  Mol Pharmacol       Date:  2003-12       Impact factor: 4.436

2.  Bone protection by estrens occurs through non-tissue-selective activation of the androgen receptor.

Authors:  Sara H Windahl; René Galien; Riccardo Chiusaroli; Philippe Clément-Lacroix; Frederic Morvan; Liên Lepescheux; François Nique; William C Horne; Michèle Resche-Rigon; Roland Baron
Journal:  J Clin Invest       Date:  2006-09       Impact factor: 14.808

Review 3.  Drugs used to treat osteoporosis: the critical need for a uniform nomenclature based on their action on bone remodeling.

Authors:  B Lawrence Riggs; A Michael Parfitt
Journal:  J Bone Miner Res       Date:  2004-11-16       Impact factor: 6.741

4.  Effects of ultralow-dose transdermal estradiol on bone mineral density: a randomized clinical trial.

Authors:  Bruce Ettinger; Kristine E Ensrud; Robert Wallace; Karen C Johnson; Steven R Cummings; Vladimir Yankov; Eric Vittinghoff; Deborah Grady
Journal:  Obstet Gynecol       Date:  2004-09       Impact factor: 7.661

5.  Dose-response of estrogen on bone versus the uterus in ovariectomized mice.

Authors:  Ulrike I L Modder; B Lawrence Riggs; Thomas C Spelsberg; Daniel G Fraser; Elizabeth J Atkinson; Rudolf Arnold; Sundeep Khosla
Journal:  Eur J Endocrinol       Date:  2004-10       Impact factor: 6.664

6.  The skeletal effects of glucocorticoid excess override those of orchidectomy in mice.

Authors:  Robert S Weinstein; Dan Jia; Cara C Powers; Scott A Stewart; Robert L Jilka; A Michael Parfitt; Stavros C Manolagas
Journal:  Endocrinology       Date:  2004-01-08       Impact factor: 4.736

7.  Estren behaves as a weak estrogen rather than a nongenomic selective activator in the mouse uterus.

Authors:  Sylvia C Hewitt; Jennifer Collins; Sherry Grissom; Katherine Hamilton; Kenneth S Korach
Journal:  Endocrinology       Date:  2006-02-09       Impact factor: 4.736

8.  Reversal of bone loss in mice by nongenotropic signaling of sex steroids.

Authors:  S Kousteni; J R Chen; T Bellido; L Han; A A Ali; C A O'Brien; L Plotkin; Q Fu; A T Mancino; Y Wen; A M Vertino; C C Powers; S A Stewart; R Ebert; A M Parfitt; R S Weinstein; R L Jilka; S C Manolagas
Journal:  Science       Date:  2002-10-25       Impact factor: 47.728
  8 in total
  6 in total

1.  Non-nuclear-initiated actions of the estrogen receptor protect cortical bone mass.

Authors:  Shoshana M Bartell; Li Han; Ha-neui Kim; Sung Hoon Kim; John A Katzenellenbogen; Benita S Katzenellenbogen; Ken L Chambliss; Philip W Shaul; Paula K Roberson; Robert S Weinstein; Robert L Jilka; Maria Almeida; Stavros C Manolagas
Journal:  Mol Endocrinol       Date:  2013-02-26

Review 2.  Estrogens and Androgens in Skeletal Physiology and Pathophysiology.

Authors:  Maria Almeida; Michaël R Laurent; Vanessa Dubois; Frank Claessens; Charles A O'Brien; Roger Bouillon; Dirk Vanderschueren; Stavros C Manolagas
Journal:  Physiol Rev       Date:  2017-01       Impact factor: 37.312

3.  Induction of osteoblast differentiation by selective activation of kinase-mediated actions of the estrogen receptor.

Authors:  Stavroula Kousteni; Maria Almeida; Li Han; Teresita Bellido; Robert L Jilka; Stavros C Manolagas
Journal:  Mol Cell Biol       Date:  2006-12-11       Impact factor: 4.272

Review 4.  The role of estrogen and androgen receptors in bone health and disease.

Authors:  Stavros C Manolagas; Charles A O'Brien; Maria Almeida
Journal:  Nat Rev Endocrinol       Date:  2013-09-17       Impact factor: 43.330

5.  Tissue selectivity of the anabolic steroid, 19-nor-4-androstenediol-3beta,17beta-diol in male Sprague Dawley rats: selective stimulation of muscle mass and bone mineral density relative to prostate mass.

Authors:  Stephanie T Page; Brett T Marck; James M Tolliver; Alvin M Matsumoto
Journal:  Endocrinology       Date:  2007-12-20       Impact factor: 4.736

Review 6.  Sex steroid actions in male bone.

Authors:  Dirk Vanderschueren; Michaël R Laurent; Frank Claessens; Evelien Gielen; Marie K Lagerquist; Liesbeth Vandenput; Anna E Börjesson; Claes Ohlsson
Journal:  Endocr Rev       Date:  2014-09-09       Impact factor: 19.871
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.